Risk-Sharing Drug Rebate Contracts: Do They Live Up To The Hype?
Executive Summary
Manufacturers and payers will continue to work on innovative pricing arrangements, roundtable panelists said, but they are likely to be less complex and resource intensive than many of the risk-sharing contracts announced to date, particularly in Europe.